# SEPSIS â€” SOURCES

---

## Core Guidelines

### Surviving Sepsis Campaign (2021)
Rhodes A, et al.
Intensive Care Med. 2021.

Key contribution:
- 1-hour bundle
- Updated fluid strategy
- Vasopressor algorithms

---

## Sepsis-3 Definitions

Singer M, et al.
JAMA. 2016.

Key contribution:
- SOFA-based definition
- Removal of SIRS requirement

---

## Landmark Trials

### Rivers Trial (Early Goal-Directed Therapy)
NEJM 2001
- Introduced aggressive early resuscitation

### ProCESS / ARISE / ProMISe Trials
2014-2015
- Showed protocolized EGDT not superior to modern care

---

## Fluid Studies

SMART Trial (2018)
NEJM
- Balanced crystalloids superior to saline

---

## Vasopressor Evidence

VASST Trial
NEJM 2008
- Vasopressin adjunct benefit

---

## Steroid Evidence

ADRENAL Trial (2018)
- Faster shock reversal

APROCCHSS Trial (2018)
- Mortality reduction

---

## Sepsis Pathophysiology Reviews

Hotchkiss RS, et al.
Nat Rev Dis Primers. 2016.

---

## Epidemiology

Global burden:
~11 million deaths/year worldwide.

Major causes:
- Pneumonia
- Intra-abdominal infections
- Urosepsis

---

## Recommended Reading

- Surviving Sepsis Campaign Guidelines 2021
- Sepsis-3 Definitions (JAMA)
- SCCM Educational Modules
